Participation of COX-1 and COX-2 in the contractile effect of phenylephrine in prepubescent and old rats |
Guevara-Balcazar, Gustavo
(Cardiovascular Pharmacology and Hyperbaric Experimental Medicine, Escuela Superior de Medicina, Instituto Politecnico Nacional)
Ramirez-Sanchez, Israel (Cardiovascular Pharmacology and Hyperbaric Experimental Medicine, Escuela Superior de Medicina, Instituto Politecnico Nacional) Mera-Jimenez, Elvia (Cardiovascular Pharmacology and Hyperbaric Experimental Medicine, Escuela Superior de Medicina, Instituto Politecnico Nacional) Rubio-Gayosso, Ivan (Cardiovascular Pharmacology and Hyperbaric Experimental Medicine, Escuela Superior de Medicina, Instituto Politecnico Nacional) Aguilar-Najera, Maria Eugenia (Cardiovascular Pharmacology and Hyperbaric Experimental Medicine, Escuela Superior de Medicina, Instituto Politecnico Nacional) Castillo-Hernandez, Maria C. (Cardiovascular Pharmacology and Hyperbaric Experimental Medicine, Escuela Superior de Medicina, Instituto Politecnico Nacional) |
1 | Castillo-Hernandez MC, Guevara-Balcazar G, Lopez-Sanchez P, Asbun-Bojalil J, Lopez RM, Castillo EF, Castillo-Henkel C. The influence of constitutive COX-2 in smooth muscle tissue on the contractile effect of phenylephrine in the rat abdominal aorta. Front Biosci (Elite Ed). 2010;2:441-448. |
2 | Kahonen M, Tolvanen JP, Sallinen K, Wu X, Porsti I. Influence of gender on control of arterial tone in experimental hypertension. Am J Physiol. 1998;275:H15-22. |
3 | Pairet M, Engelhardt G. Distinct isoforms (COX-1 and COX-2) of cyclooxygenase: possible physiological and therapeutic implications. Fundam Clin Pharmacol. 1996;10:1-17. DOI |
4 | Smith WL, Dewitt DL. Prostaglandin endoperoxide H synthases-1 and -2. Adv Immunol. 1996;62:167-215. |
5 | Zidar N, Dolenc-Strazar Z, Jeruc J, Jerse M, Balazic J, Gartner U, Jermol U, Zupanc T, Stajer D. Expression of cyclooxygenase-1 and cyclooxygenase-2 in the normal human heart and in myocardial infarction. Cardiovasc Pathol. 2007;16:300-304. DOI |
6 | Feng L, Sun W, Xia Y, Tang WW, Chanmugam P, Soyoola E, Wilson CB, Hwang D. Cloning two isoforms of rat cyclooxygenase: differential regulation of their expression. Arch Biochem Biophys. 1993;307:361-368. DOI |
7 | O'Neill GP, Ford-Hutchinson AW. Expression of mRNA for cyclooxygenase-1 and cyclooxygenase-2 in human tissues. FEBS Lett. 1993;330:156-160. |
8 | Iseki S. Immunocytochemical localization of cyclooxygenase-1 and cyclooxygenase-2 in the rat stomach. Histochem J. 1995;27:323-328. DOI |
9 | Connolly C, McCormick PA, Docherty JR. Effects of the selective cyclooxygenase-2 inhibitor nimesulide on vascular contractions in endothelium-denuded rat aorta. Eur J Pharmacol. 1998;352:53-58. DOI |
10 | Luksha L, Poston L, Gustafsson JA, Aghajanova L, Kublickiene K. Gender-specific alteration of adrenergic responses in small femoral arteries from estrogen receptor-beta knockout mice. Hypertension. 2005;46:1163-1168. DOI |
11 | Gregg AR, Thompson LP, Herrig JE, Weiner CP. Regionalization of endothelium-dependent relaxation in the thoracic aorta of pregnant and nonpregnant guinea pigs. J Vasc Res. 1995;32:106-111. DOI |
12 | Perrone MG, Scilimati A, Simone L, Vitale P. Selective COX-1 inhibition: A therapeutic target to be reconsidered. Curr Med Chem. 2010;17:3769-3805. DOI |
13 | Matz RL, Van Overloop B, Gaubert E, Gairard A. Maturation reveals a decrease in endothelium-dependent contraction induced by depolarization in the aorta of spontaneously hypertensive rats. Life Sci. 2001;69:1791-1804. DOI |
14 | Asbun-Bojalil J, Castillo EF, Escalante BA, Castillo C. Does segmental difference in alpha 1-adrenoceptor subtype explain contractile difference in rat abdominal and thoracic aortae? Vascul Pharmacol. 2002;38:169-175. DOI |
15 | Lamb VL, Schwartz AJ, Rohn WR, Kaiser L. Cyclooxygenase inhibitors depress norepinephrine constriction of rat abdominal, but not thoracic, aorta. Eur J Pharmacol. 1994;256:221-226. DOI |
16 | Asano K, Lilly CM, Drazen JM. Prostaglandin G/H synthase-2 is the constitutive and dominant isoform in cultured human lung epithelial cells. Am J Physiol. 1996;271:L126-131. |
17 | Hennan JK, Huang J, Barrett TD, Driscoll EM, Willens DE, Park AM, Crofford LJ, Lucchesi BR. Effects of selective cyclooxygenase-2 inhibition on vascular responses and thrombosis in canine coronary arteries. Circulation. 2001;104:820-825. DOI |
18 | LaBelle EF, Polyak E. Norepinephrine stimulates arachidonic acid release from vascular smooth muscle via activation of cPLA2. Am J Physiol. 1998;274:C1129-1137. DOI |
19 | Vane JR, Bakhle YS, Botting RM. Cyclooxygenases 1 and 2. Annu Rev Pharmacol Toxicol. 1998;38:97-120. DOI |
20 | Morita I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 2002;68-69:165-175. DOI |
21 | Qi Z, Cai H, Morrow JD, Breyer MD. Differentiation of cyclooxygenase 1- and 2-derived prostanoids in mouse kidney and aorta. Hypertension. 2006;48:323-328. DOI |
22 | Kangussu LM, Olivon VC, Arifa RD, Araujo N, Reis D, Assis MT, Soriani FM, de Souza Dda G, Bendhack LM, Bonaventura D. Enhancement on reactive oxygen species and COX-1 mRNA levels modulate the vascular relaxation induced by sodium nitroprusside in denuded mice aorta. Fundam Clin Pharmacol. 2015;29:150-163. DOI |
23 | Kumar P, Padi SS, Naidu PS, Kumar A. Cyclooxygenase inhibition attenuates 3-nitropropionic acid-induced neurotoxicity in rats: possible antioxidant mechanisms. Fundam Clin Pharmacol. 2007;21:297-306. DOI |